Today The Wall Street Associates Invests $304,000 in Trupanion Inc (TRUP)

Today The Wall Street Associates Invests $304,000 in Trupanion Inc (TRUP)

Wall Street Associates acquired a new position in shares of Trupanion Inc (NYSE:TRUP) during the fourth quarter, according to its most recent filing with the SEC. The fund acquired 19,600 shares of the company’s stock, valued at approximately $304,000. Wall Street Associates owned about 0.07% of Trupanion as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Immersion Capital LLP bought a new position in shares of Trupanion during the second quarter worth approximately $18,374,000. United Services Automobile Association bought a new position in shares of Trupanion during the third quarter worth approximately $1,452,000. State Street Corp increased its position in shares of Trupanion by 50.5% in the second quarter. State Street Corp now owns 199,861 shares of the company’s stock worth $2,650,000 after buying an additional 67,026 shares during the last quarter. Cheyne Capital Management UK LLP bought a new position in shares of Trupanion during the third quarter worth approximately $1,013,000. Finally, Jefferies Group LLC bought a new position in shares of Trupanion during the second quarter worth approximately $663,000.

Trupanion Inc (NYSE:TRUP) traded up 1.46% during mid-day trading on Wednesday, reaching $15.24. 8,913 shares of the company’s stock traded hands. The firm has a 50-day moving average price of $15.41 and a 200-day moving average price of $15.66. Trupanion Inc has a 1-year low of $7.84 and a 1-year high of $17.68. The stock’s market cap is $445.82 million.

Trupanion (NYSE:TRUP) last announced its quarterly earnings results on Tuesday, November 1st. The company reported ($0.06) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.06). The firm earned $48.40 million during the quarter, compared to analyst estimates of $48.17 million. The business’s revenue was up 27.7% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.17) earnings per share. Equities research analysts anticipate that Trupanion Inc will post ($0.23) EPS for the current fiscal year.

TRUP has been the topic of a number of research analyst reports. RBC Capital Markets reaffirmed a “buy” rating and set a $18.00 price objective on shares of Trupanion in a research report on Thursday, November 3rd. Zacks Investment Research downgraded shares of Trupanion from a “buy” rating to a “hold” rating in a research report on Friday, November 25th. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $15.75.

In other Trupanion news, Director Howard E. Rubin sold 28,751 shares of the firm’s stock in a transaction that occurred on Wednesday, November 30th. The shares were sold at an average price of $17.00, for a total transaction of $488,767.00. Following the sale, the director now directly owns 10,352 shares in the company, valued at approximately $175,984. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Darryl Rawlings sold 3,500 shares of the firm’s stock in a transaction that occurred on Wednesday, November 2nd. The stock was sold at an average price of $14.95, for a total transaction of $52,325.00. Following the sale, the insider now owns 1,519,505 shares in the company, valued at $22,716,599.75. The disclosure for this sale can be found here. Insiders sold a total of 73,404 shares of company stock worth $1,220,718 over the last quarter.

Trupanion Company Profile

Trupanion, Inc provides a medical insurance plan for cats and dogs across the United States, Canada and Puerto Rico. The Company operates through two segments: subscription business and other business. The subscription business segment includes monthly subscriptions related to the Company’s medical plan, which are marketed directly to consumers.

Want to see what other hedge funds are holding TRUP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Trupanion Inc (NYSE:TRUP).

Related posts

Leave a Comment